{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:44:16Z","timestamp":1792806256694,"version":"4.5.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0239926","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T17:32:39Z","timestamp":1602264759000},"page":"e0239926","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Epidemiological impact and cost-effectiveness of universal meningitis b vaccination among college students prior to college entry"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1818-0148","authenticated-orcid":true,"given":"Grace S.","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"pone.0239926.ref001","unstructured":"GlaxoSmithKline. Get the Facts about Meningitis B. https:\/\/www.meningitisb.com\/index.html Published 2017. Accessed."},{"key":"pone.0239926.ref002","unstructured":"Centers for Disease Control and Prevention. Meningococcal Vaccination: What Everyone Should Know. https:\/\/www.cdc.gov\/vaccines\/vpd\/mening\/index.html. Published 2019. Accessed."},{"key":"pone.0239926.ref003","unstructured":"Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report.pdf. Published 2016. Accessed September 19, 2019."},{"key":"pone.0239926.ref004","unstructured":"Meningitis B Action Project: About Meningitis B. https:\/\/meningitisbactionproject.org\/about-meningitis. Accessed."},{"key":"pone.0239926.ref005","doi-asserted-by":"crossref","first-page":"520","DOI":"10.15585\/mmwr.mm6520a3","article-title":"Notes from the Field: Outbreak of Serogroup B Meningococcal Disease at a University\u2014California","volume":"65","author":"HH Biswas","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pone.0239926.ref006","article-title":"US College Students Are at Increased Risk for Serogroup B Meningococcal Disease","author":"GS Marshall","year":"2019","journal-title":"Journal of the Pediatric Infectious Diseases Society"},{"issue":"2","key":"pone.0239926.ref007","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.amepre.2018.09.020","article-title":"Cost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults","volume":"56","author":"IL Leeds","year":"2019","journal-title":"American journal of preventive medicine"},{"issue":"2","key":"pone.0239926.ref008","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.vaccine.2016.11.076","article-title":"Modelling the cost-effectiveness of catch-up 'MenB' (Bexsero) vaccination in England","volume":"35","author":"H Christensen","year":"2017","journal-title":"Vaccine"},{"key":"pone.0239926.ref009","first-page":"g5725","article-title":"Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study","volume":"349","author":"H Christensen","year":"2014","journal-title":"BMJ (Clinical research ed)"},{"key":"pone.0239926.ref010","unstructured":"Precision Vaccinations. Is the meningitis B vaccine \u2018cost-effective\u2019 in the UK? https:\/\/www.precisionvaccinations.com\/nhs-offers-free-meningitis-b-vaccinations-2-months-age-additional-doses-4-and-12-months Published 2018. Accessed."},{"issue":"4","key":"pone.0239926.ref011","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1473-3099(16)00139-0","article-title":"Costs, compassion, and the case for vaccination","volume":"16","year":"2016","journal-title":"The Lancet Infectious diseases"},{"issue":"29","key":"pone.0239926.ref012","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1016\/j.vaccine.2016.04.004","article-title":"Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero((R)) to reduce meningococcal group B disease in Germany","volume":"34","author":"H Christensen","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"pone.0239926.ref013","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/21645515.2015.1010885","article-title":"Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country","volume":"11","author":"G Izquierdo","year":"2015","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"1","key":"pone.0239926.ref014","doi-asserted-by":"crossref","first-page":"e1002495","DOI":"10.1371\/journal.pmed.1002495","article-title":"The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study","volume":"15","author":"R Yaesoubi","year":"2018","journal-title":"PLoS medicine"},{"issue":"11","key":"pone.0239926.ref015","doi-asserted-by":"crossref","first-page":"e0188595","DOI":"10.1371\/journal.pone.0188595","article-title":"Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt","volume":"12","author":"A Kuznik","year":"2017","journal-title":"PloS one"},{"issue":"1","key":"pone.0239926.ref016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/2051013616681365","article-title":"Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United States","volume":"5","author":"A Banzhoff","year":"2017","journal-title":"Therapeutic advances in vaccines"},{"issue":"24","key":"pone.0239926.ref017","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1614474","article-title":"A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults","volume":"377","author":"L Ostergaard","year":"2017","journal-title":"The New England journal of medicine"},{"issue":"3","key":"pone.0239926.ref018","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3201\/eid2503.181574","article-title":"University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013\u20132018","volume":"25","author":"HM Soeters","year":"2019","journal-title":"Emerging infectious diseases"},{"key":"pone.0239926.ref019","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12879-015-1015-8","article-title":"The impact of aggregating serogroups in dynamic models of Neisseria meningitidis transmission.","volume":"15","author":"KD Poore","year":"2015","journal-title":"BMC infectious diseases"},{"issue":"3","key":"pone.0239926.ref020","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social contacts and mixing patterns relevant to the spread of infectious diseases","volume":"5","author":"J Mossong","year":"2008","journal-title":"PLoS medicine"},{"issue":"3","key":"pone.0239926.ref021","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1017\/S0950268805005339","article-title":"The natural history of meningococcal carriage and disease","volume":"134","author":"CL Trotter","year":"2006","journal-title":"Epidemiology and infection"},{"issue":"Suppl 2","key":"pone.0239926.ref022","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","article-title":"Meningococcal disease: clinical presentation and sequelae","volume":"30","author":"D Pace","year":"2012","journal-title":"Vaccine"},{"key":"pone.0239926.ref023","volume-title":"Vaccines for the 21st Century: A Tool for Decisionmaking","author":"Institute of Medicine (US) Committee to Study Priorities for Vaccine Development","year":"2000"},{"issue":"11","key":"pone.0239926.ref024","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.apjtm.2017.10.004","article-title":"Meningococcal disease, a clinical and epidemiological review","volume":"10","author":"RS Batista","year":"2017","journal-title":"Asian Pac J Trop Med"},{"issue":"5","key":"pone.0239926.ref025","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment","volume":"13","author":"U Vogel","year":"2013","journal-title":"The Lancet Infectious diseases"},{"issue":"5","key":"pone.0239926.ref026","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1542\/peds.2004-2514","article-title":"Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States","volume":"115","author":"CW Shepard","year":"2005","journal-title":"Pediatrics"},{"issue":"1","key":"pone.0239926.ref027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/524041","article-title":"Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States","volume":"46","author":"IR Ortega-Sanchez","year":"2008","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"1","key":"pone.0239926.ref028","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4161\/hv.7.1.13692","article-title":"Cost of acute hospitalization and post-discharge follow-up care for meningococcal disease in the US","volume":"7","author":"KL Davis","year":"2011","journal-title":"Human vaccines"},{"key":"pone.0239926.ref029","first-page":"57","article-title":"Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment\u2014United States, 2003","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pone.0239926.ref030","unstructured":"Centers for Disease Control and Prevention. Vaccine Price List. Vaccines for Children Program. https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/awardees\/vaccine-management\/price-list\/index.html. Published 2019. Accessed."},{"key":"pone.0239926.ref031","unstructured":"Centers for Medicare and Medicaid Services (CMS). Physician fee schedule. Published 2020. Accessed."},{"issue":"Suppl 1","key":"pone.0239926.ref032","first-page":"S246","article-title":"683. Cost Calculator for Mass Vaccination Response to a US College Campus Outbreak of Serogroup B Meningococcal Disease","volume":"5","author":"EM La","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"pone.0239926.ref033","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine","volume":"316","author":"GD Sanders","year":"2016","journal-title":"Jama"},{"issue":"9","key":"pone.0239926.ref034","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1017\/S001216229900122X","article-title":"Causes of excess mortality in cerebral palsy","volume":"41","author":"D Strauss","year":"1999","journal-title":"Developmental medicine and child neurology"},{"key":"pone.0239926.ref035","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. Fast stats A to Z: life expectancy. Available at: www.cdc.gov\/nchs\/fastats\/lifexpec.htm. Accessed November 5, 2004."},{"issue":"12","key":"pone.0239926.ref036","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/hec.3259","article-title":"Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis","volume":"25","author":"H Al-Janabi","year":"2016","journal-title":"Health economics"},{"key":"pone.0239926.ref037","unstructured":"CPI Inflation Calculator. https:\/\/www.officialdata.org\/us\/inflation\/1832?amount=20000. Accessed."},{"key":"pone.0239926.ref038","volume-title":"Cost-Effectiveness in Health and Medicine","year":"1996"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0239926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T17:33:31Z","timestamp":1602264811000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0239926"}},"subtitle":[],"editor":[{"given":"Bart","family":"Ferket","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0239926","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]}}}